Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 3/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | MGLL | Q99685 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | HTR1A | P08908 | 1/20 | 0.39 |
| ▸ | HTR7 | P34969 | 1/20 | 0.39 |
| ▸ | DCTPP1 | Q9H773 | 1/20 | 0.39 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.38 |
| ▸ | DCLK1 | O15075 | 1/20 | 0.38 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.38 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.38 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.38 |
| ▸ | CSF1R | P07333 | 1/20 | 0.38 |
| ▸ | FER | P16591 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30955443 | 1.00 | ATM (0.41) | ATML3MBTL1KDM4EALDH1A1FAAH | |
| SCHEMBL12362763 | 1.00 | ATM (0.41) | ATML3MBTL1KDM4EALDH1A1FAAH | |
| SCHEMBL18680580 | 0.97 | ALDH1A1 (0.42) | ATML3MBTL1KDM4EALDH1A1FAAH | |
| SCHEMBL30250575 | 0.95 | L3MBTL1 (0.50) | ATML3MBTL1KDM4EALDH1A1FAAH | |
| SCHEMBL29616363 | 0.95 | L3MBTL1 (0.50) | ATML3MBTL1KDM4EALDH1A1FAAH | |
| SCHEMBL14822296 | 0.95 | L3MBTL1 (0.50) | ATML3MBTL1KDM4EALDH1A1FAAH | |
| SCHEMBL23468855 | 0.94 | L3MBTL1 (0.49) | ATML3MBTL1KDM4EALDH1A1FAAH | |
| SCHEMBL26720834 | 0.94 | L3MBTL1 (0.49) | ATML3MBTL1KDM4EALDH1A1FAAH | |
| SCHEMBL30817433 | 0.93 | L3MBTL1 (0.47) | ATML3MBTL1KDM4EALDH1A1FAAH | |
| SCHEMBL17379703 | 0.93 | L3MBTL1 (0.47) | ATML3MBTL1KDM4EALDH1A1FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12433151-B2 | Heterocyclic compound, light-emitting device including the heterocyclic compound, and electronic apparatus including the light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2025-09-30 | — | — | US | disclosed |
| CN-114447241-A | Heterocyclic compound, light-emitting device, and electronic device | 三星显示有限公司 | 2022-05-06 | — | — | CN | disclosed |
| US-20220140261-A1 | HETEROCYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12433151-B2 | Heterocyclic compound, light-emitting device including the heterocyclic compound, and electronic apparatus including the light-emitting device | CRY1, CYP2E1, CYP1A1 | ATM 4470/4885L3MBTL1 1224/4885KDM4E 2674/4885 |
| US-20220140261-A1 | HETEROCYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE | CRY1, CYP2E1, CYP1A1 | ATM 4470/4885L3MBTL1 1224/4885KDM4E 2674/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.